Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Prepaid Assets (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Prepaid Assets for 16 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Prepaid Assets fell 22.98% to $1.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.5 million, a 22.98% decrease, with the full-year FY2024 number at $1.6 million, up 20.38% from a year prior.
  • Prepaid Assets was $1.5 million for Q3 2025 at Xtant Medical Holdings, down from $1.5 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $1.9 million in Q3 2024 to a low of $424000.0 in Q2 2022.
  • A 5-year average of $1.2 million and a median of $1.2 million in 2021 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: crashed 48.73% in 2022, then soared 178.45% in 2023.
  • Xtant Medical Holdings' Prepaid Assets stood at $844000.0 in 2021, then dropped by 20.26% to $673000.0 in 2022, then skyrocketed by 97.62% to $1.3 million in 2023, then rose by 20.38% to $1.6 million in 2024, then fell by 8.93% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Prepaid Assets are $1.5 million (Q3 2025), $1.5 million (Q2 2025), and $1.4 million (Q1 2025).